Trade Puma Biotechnology, Inc. - PBYI CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.0320 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023485% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001262% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 2.944 |
| Open | 2.904 |
| 1-Year Change | -44.9% |
| Day's Range | 2.894 - 3.014 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Mar 31, 2025 | 2.9440 | -0.1500 | -4.85% | 3.0940 | 3.0940 | 2.9140 |
| Mar 28, 2025 | 3.1140 | 0.0700 | 2.30% | 3.0440 | 3.1540 | 3.0240 |
| Mar 27, 2025 | 3.1340 | 0.0500 | 1.62% | 3.0840 | 3.1440 | 3.0640 |
| Mar 26, 2025 | 3.0940 | -0.1500 | -4.62% | 3.2440 | 3.2440 | 3.0940 |
| Mar 25, 2025 | 3.2440 | -0.1000 | -2.99% | 3.3440 | 3.4540 | 3.2340 |
| Mar 24, 2025 | 3.4540 | -0.0100 | -0.29% | 3.4640 | 3.5040 | 3.3240 |
| Mar 21, 2025 | 3.4940 | 0.1600 | 4.80% | 3.3340 | 3.5140 | 3.3140 |
| Mar 20, 2025 | 3.3840 | -0.0200 | -0.59% | 3.4040 | 3.5940 | 3.3740 |
| Mar 19, 2025 | 3.4340 | 0.1700 | 5.21% | 3.2640 | 3.5040 | 3.2640 |
| Mar 18, 2025 | 3.3140 | 0.1400 | 4.41% | 3.1740 | 3.3940 | 3.1240 |
| Mar 17, 2025 | 3.2140 | -0.0600 | -1.83% | 3.2740 | 3.3140 | 3.1440 |
| Mar 14, 2025 | 3.3040 | -0.0100 | -0.30% | 3.3140 | 3.4440 | 3.2740 |
| Mar 13, 2025 | 3.3240 | -0.1300 | -3.76% | 3.4540 | 3.5040 | 3.3240 |
| Mar 12, 2025 | 3.4940 | 0.1500 | 4.49% | 3.3440 | 3.5540 | 3.3440 |
| Mar 11, 2025 | 3.3740 | 0.0400 | 1.20% | 3.3340 | 3.4240 | 3.2540 |
| Mar 10, 2025 | 3.3940 | -0.0100 | -0.29% | 3.4040 | 3.5540 | 3.3340 |
| Mar 7, 2025 | 3.4740 | -0.0800 | -2.25% | 3.5540 | 3.6440 | 3.4240 |
| Mar 6, 2025 | 3.5940 | 0.1400 | 4.05% | 3.4540 | 3.7140 | 3.4540 |
| Mar 5, 2025 | 3.5240 | 0.2800 | 8.63% | 3.2440 | 3.5240 | 3.2440 |
| Mar 4, 2025 | 3.4140 | 0.1900 | 5.89% | 3.2240 | 3.4240 | 3.2240 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Puma Biotechnology Company profile
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States. Its drug candidates include PB272 neratinib (oral) for the treatment of early stage breast cancer, metastatic breast cancer, non-small cell lung cancer, HER2 mutation-positive solid tumors, and HER2-mutated non-amplified breast cancer; and PB272 neratinib (intravenous). The company also develops PB357, an orally administered agent that is an irreversible tyrosine kinase inhibitor that blocks signal transduction through the epidermal growth factor receptors, HER1, HER2, and HER4. It has a license agreement with Pfizer, Inc. for the development, manufacture, and commercialization of PB272 neratinib (oral), PB272 neratinib (intravenous), PB357, and certain related compounds. Puma Biotechnology, Inc. was founded in 2010 and is headquartered in Los Angeles, California.| Industry: | Biotechnology & Medical Research (NEC) |
10880 Wilshire Blvd.
Suite 2150
LOS ANGELES
CALIFORNIA 90024
US
News
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025
Coffee price forecast: 2025-2030 third-party coffee target
Coffee prices have cooled considerably in the past few months. Is a rebound in store or will they continue to fall?
09:42, 12 March 2025
The Simpsons predicted XRP to hit $589: Has the show got it right again?
Did the animated TV show predict a breakout for the XRP cryptocurrency?
11:00, 11 March 2025
Rolls-Royce share price forecast: third- party price target
Our Rolls-Royce share price forecast looks at the outlook for the FTSE 100-listed engineering company after a tough few years.
14:58, 10 March 2025
Gasoline petrol price forecast 2025-2030: Third-party price target
Discover third-party gasoline (petrol) price predictions for 2025 and beyond, with analyst targets, historical prices, and trading strategies.
10:27, 3 March 2025
USD forecast - third party data round up
The DXY hit a seven-month low in January, just a few months after a multi-decade peak in late September.
10:02, 27 February 2025
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025People also watch
Still looking for a broker you can trust?
Join the 710,000+ traders worldwide that chose to trade with Capital.com